NCD Policy Lab

26/01/2026

📸 A photograph by Antoine Martin featured in The Lancet Highlights 2025

A photograph by Antoine Martin, taken as part of the exhibition, has been selected and published in The Lancet (Vol. 406, December 20/27, 2025) in the special feature “Highlights 2025: Illuminating Health Stories.”

Being featured in one of the world’s most prestigious medical journals is a remarkable recognition of Antoine Martin’s work and of the power of photography to tell meaningful health stories especially this photo, which depicts the lived experience of people with hashtag . It is also a valuable opportunity to highlight the exhibition LIVING WITH: https://ncdpolicylab.org/activities/exhibition/living-with

Warm congratulations to Antoine Martin on this outstanding achievement ✨
🔗 Discover the feature: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02550-4/abstract

hashtag hashtag hashtag

21/01/2026

New year. Same challenge.

Insulin shortages continue to affect countries worldwide across income levels and health systems.

A report published in December documented insulin shortages and stockouts between 2023 and 2025, showing that this is not an isolated problem, but a global and systemic one.

🎥 Watch the video to see the key findings.

📄 Full report available : https://ncdpolicylab.org/resources/factsheets/documenting-global-insulin-shortages-and-stockouts-2023-2025-comprehensive-overview-using-various-data-sources?utm_source=linkedin&utm_medium=social&utm_campaign=ncd-alliance-social-media&utm_content=ap_wnb9qkmmvi

13/01/2026

🆕 Updated resource now available

The factsheet on Sources of insulin, oral medicines, and medical devices for diabetes for low- and middle-income countries has been updated with the latest information!
It informs key actors (from national programs and procurement agencies/departments) on existing mechanisms that can be used to facilitate access to essential diabetes medicines and medical devices for regular procurement, especially during procurement system disruptions or stock shortages.

👉 Explore the updated factsheet: https://ncdpolicylab.org/resources/factsheets/-1

**The information included in this document has been confirmed by United Nations (UN) agencies, manufacturers or suppliers and is subject to change and updates. This information is not in support of any agency, manufacturer, or supplier. It is for information purposes only.

12/01/2026

✨ Happy new year and best Wishes for 2026 from NCD Policy Lab!

In a world where NCDs remain a leading cause of preventable suffering, the role of science-to-policy translation, regulatory strengthening, and health system collaboration has never been more critical.
May this year advance bold thinking, impactful partnerships, and policy solutions that truly improve access to medicines and technologies.

Wishing all partners and stakeholders a year of progress, purpose, and policy impact.✨

23/12/2025

🎄✨As #2025 draws to a close, the NCD Policy Lab reflects on a year marked by collaboration, evidence generation, and continued engagement to advance access to essential medicines for noncommunicable diseases (NCDs).

Throughout the year, and despite ongoing global challenges, the NCD Policy Lab and its partners strengthened efforts to generate policy-relevant evidence, translate research into actionable outputs, facilitate dialogue between researchers and policymakers, and support collective action to address persistent barriers to access to medicines, diagnostics, and medical devices.
On behalf of all the partners involved in the NCD Policy Lab, warmest wishes are extended to the NCD Policy Lab’s audience & to everyone who has contributed to advancing its mission. The NCD Policy Lab looks forward continuing this important work in the coming year to drive the NCD forward.

🌟 Wishing everyone a joyful holiday season and a New Year filled with inspiration and impact!

Read through for some highlights throughout the year

22/12/2025

Discover highlights from the “New Year’s Table for Type 1 Diabetes” event organized by our partner HPAC, held in Osha on December 14.

During the event, a nutrition expert guided participants through the principles of appropriate nutrition and meal planning for type 1 diabetes, with special attention to the festive season. The practical, hands-on approach helped reinforce key knowledge and build greater confidence in managing diabetes, particularly during the holidays✨

16/12/2025

On 23 September 2025, alongside the UN General Assembly ( ) in New York, the NCD Policy Lab co-organised with NCD Alliance, Access to Medicine Foundation, and Medicines Patent Pool the event “Bridging the Gap: Scaling Innovative Approaches to NCD Medicine Access in LMICs.”
The discussion explored strategies to improve access to treatments for noncommunicable diseases ( ) and mental health conditions in low- and middle-income countries.

By bringing together leaders from global health agencies, pharmaceutical companies, governments, regional health bodies, and civil society, the event highlighted a shared commitment to closing treatment gaps and strengthening country responses to the growing burden of NCDs.

📽️ This recently shared video showcases the main takeaways and promising approaches discussed at the meeting:

This video provides a concise summary of a high-level event held alongside the UN General Assembly, where global leaders voiced strong support for the new Political…

11/12/2025

🔔 Insulin shortages and stockouts are a global problem across geographies and income groups.

In many settings, these disruptions are not occasional but chronic, undermining continuity of care, placing unnecessary pressure on people with diabetes and providers, and widening existing health inequities. Despite being discovered more than a century ago, insulin access remains uneven and, in far too many contexts, uncertain.

"Documenting global Insulin Shortages and Stockouts 2023–2025: Comprehensive overview using various data sources" provides a comprehensive overview of the issue of insulin and , collecting information for the lay press, a review of WHO and government databases as well as questions to the three major insulin manufacturers.

Access to the report here and discover the calls to action proposed👉 https://ncdpolicylab.org/resources/factsheets/documenting-global-insulin-shortages-and-stockouts-2023-2025-comprehensive-overview-using-various-data-sources

11/12/2025

11/12/2025

03/12/2025

Last week, the NCD Policy Lab joined forces with the NCD Alliance to host a focused workshop on advancing access to essential medicines, diagnostics and medical devices ✨

The session brought together voices from World Health Organization (WHO), global access initiatives, organisations and private-sector partners, creating a unique space to align priorities. This workshop was a true success, showcasing the progress and development of solutions first envisioned during last June’s 🚀

A huge thank-you to all participants for their energy, expertise and forward-thinking contributions, which will help shape the next phase of global NCD advocacy.